COVID-19 SOLUTION TO PREVENT ITS REPLICATION AND ACTION IN THE RESPIRATORY TRACT
Journal: International Journal of Advanced Research (Vol.8, No. 6)Publication Date: 2020-07-17
Authors : Gaurav Ajay Dubey;
Page : 34-35
Keywords : ACE2 Receptor Inhibitor DPP4 Inhibitor Aerosol;
Abstract
As this pandemic is growing very fast and the invention, trials and manufacturing of vaccine requires ample of time, so we have to find a solution to treat covid-19. We can use combination of sitagliptin-losartan in the form of aerosol which can prevent the replication and its invasion to the cell. The below given text briefly explain my perspectives regarding the use of given combination.
Other Latest Articles
- EXTRACTION OF BIOETHANOL FROM PRETREATED SAWDUST
- CONTEMPORARY ANALYSIS OF ECONOMIC STATUS OF INDIA & NEED OF SKILL MAPPING
- EMPLOYER SATISFACTION WITH THE QUALITY OF TRAINING OF GRADUATES
- ANTIBIOTIC SUSCEPTIBILITY OF MICROBIAL CONTAMINANTS FOUND IN COMMERCIALLY AVAILABLE QUININE SYRUPS AND INJECTION WATERS SOLD IN OWERRI, IMO STATE NIGERIA
- FORMATION OF PERSONNEL POTENTIAL IN THE IMPLEMENTATION OF THE STATE YOUTH POLICY OF THE RUSSIAN FEDERATION
Last modified: 2020-07-14 16:14:23